Published in CMAJ on October 26, 2004
Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study. BMC Health Serv Res (2009) 1.13
Diabetes and pre-diabetes among persons aged 35 to 60 years in eastern Uganda: prevalence and associated factors. PLoS One (2013) 1.06
How to diagnose diabetes. CMAJ (2005) 0.75
How to diagnose diabetes. CMAJ (2005) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) (2001) 8.45
Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med (2002) 5.10
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ (1998) 4.95
Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care (2003) 1.93
Projected impact of implementing the results of the diabetes prevention program in the U.S. population. Diabetes Care (2002) 1.75
The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem (1998) 1.63
The folly of population screening for type 2 diabetes. CMAJ (1999) 1.20
Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care (1999) 1.17
Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes (1978) 1.12
Undiagnosed diabetes: does it matter? CMAJ (2001) 1.12
Practice guidelines and practicing physicians-who's guiding whom? Clin Chem (2002) 1.04
Plasma glucose reference interval in a low-risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest (2001) 0.90
Preventive medicine in people at high risk for chronic disease: the value of identifying and treating diabetes. CMAJ (1999) 0.89
Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests. Scand J Clin Lab Invest (2002) 0.85
Clinical impact of the new criteria for the diagnosis of diabetes mellitus. Clin Chem Lab Med (2003) 0.81
Identifying the target population for primary prevention: the trade-offs. Diabetes Care (2002) 0.79
Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res (2006) 1.80
Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab (2014) 1.29
Association of median household income with burden of coronary artery disease among individuals with diabetes. Circ Cardiovasc Qual Outcomes (2009) 0.85
Clinical and medication profiles stratified by household income in patients referred for diabetes care. Cardiovasc Diabetol (2007) 0.82
Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial. JMIR Res Protoc (2016) 0.82
Effect of time of administration on cholesterol-lowering by psyllium: a randomized cross-over study in normocholesterolemic or slightly hypercholesterolemic subjects. Nutr J (2004) 0.79
Time study of clinical and nonclinical workload in pathology and laboratory medicine. Am J Clin Pathol (2009) 0.77
Glycemic control and use of the insulin sliding scale in hospitalized patients with diabetes. J Healthc Qual (2007) 0.76
Evidence and advocacy: are all things considered? CMAJ (2006) 0.76
A1C screening less expensive? CMAJ (2013) 0.75
Lay media reporting of rosiglitazone risk: extent, messaging and quality of reporting. Cardiovasc Diabetol (2009) 0.75
Diabetic patients with psychiatric illness. Curr Diabetes Rev (2010) 0.75
Patient profiles at a centralized, urban, diabetes education centre. Clin Invest Med (2002) 0.75